Premature Labor (PL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Premature Labor (PL) Marketed and Pipeline Drugs Report Overview
Premature/preterm labor (PL) is labor occurring after 20 and before 37 weeks gestation. Premature deliveries cause more than half of long-term morbidity and 75% of perinatal mortality. Premature labor is diagnosed primarily by history and symptoms. Symptoms of preterm labor include regular contractions before term gestational age associated with cervical change, pelvic pressure, menstrual-like cramps, watery vaginal discharge, and lower back pain. Although lower back pain is present in normal pregnancy as well, if occurring before term, it has an established association with impending preterm labor.
Key Mechanisms of Action (Marketed) | · Receptor Agonist
· Enzyme Inhibitor · Receptor Antagonist · Ion Channel Blocker |
Key Molecule Types (Marketed) | · Small Molecule
· Biologic |
Key Routes of Administration (Marketed) | · Oral
· Injection · Suppository · Inhalational |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The Premature Labor Marketed and Pipeline Drugs Market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, and pricing and reimbursement of therapy in major countries. Furthermore, the report analyzes late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for premature labor.
The report also provides actionable insights into the clinical and commercial landscapes of premature labor drugs, M&A deals, and market catalysts. These critical data will help you develop and design your in-licensing and out-licensing strategies. Furthermore, identify companies with the most robust pipelines to create smart business goals.
Key Mechanisms of Action (Pipeline) | · Receptor Agonist
· Receptor Antagonist · Enzyme Activator |
Key Molecule Types (Pipeline) | · Biologic
· Small Molecule |
Key Routes of Administration (Pipeline) | · Injection
· Oral · Suppository |
Top Sponsors (Marketed and Pipeline Drugs) | · Assiut University
· Ain Shams University · Chulalongkorn University · ObsEva SA · GSK plc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Premature Labor Marketed Drugs Market Segmentation by Mechanisms of Action
The key MoA of the marketed drugs for premature labor include receptor agonist, receptor antagonist, and enzyme activator. Most of the marketed drugs followed receptor agonist MoA in 2023 in the premature labor market.
Premature Labor Marketed Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Premature Labor Marketed Drugs
Premature Labor Marketed Drugs Market Segmentation by Routes of Administration
The key RoA of premature labor marketed drugs include oral, injection, and suppository. Most marketed drugs that were available for premature labor were oral therapies, followed by injection therapies administered through either intravenous or subcutaneous routes.
Premature Labor Marketed Drugs Market Analysis by Routes of Administration, 2023 (%)
Buy the Full Report to Know More about the RoA of Premature Labor Marketed Drugs
Premature Labor Marketed Drugs Market Segmentation by Molecule Types
The key molecule types of premature labor marketed drugs are small molecule and biologic. In 2023, the leading molecule type was small molecule.
Premature Labor Marketed Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Premature Labor Marketed Drugs
Premature Labor Pipeline Drugs Market Segmentation by Mechanisms of Action
The key MoA of the drugs in the premature labor pipeline mainly includes receptor agonists, receptor antagonists, and enzyme activators. Receptor agonists and receptor antagonists had an equal share of MoA in the premature labor market in 2023.
Premature Labor Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Premature Labor Pipeline Drugs
Premature Labor Pipeline Drugs Market Segmentation by Routes of Administration
The key RoA of the drugs in the premature labor pipeline mainly includes injection, oral, and suppository. In 2023, most pipeline drugs that were under development for premature labor were oral therapies.
Premature Labor Pipeline Drugs Market Analysis by Routes of Administration, 2023 (%)
Buy the Full Report to Know More about the RoA of Premature Labor Pipeline Drugs
Premature Labor Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types of premature labor pipeline drugs are biologic and small molecule. In 2023, the leading molecule type for premature labor pipeline drugs was small molecule.
Premature Labor Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Premature Labor Pipeline Drugs
Premature Labor Marketed and Pipeline Drugs Market – Competitive Landscape
A few of the top sponsors in the premature labor marketed and pipeline drugs market are:
- Assiut University
- Ain Shams University
- Chulalongkorn University
- ObsEva SA
- GSK plc
Assiut University sponsored the highest number of trials in 2023. ObsEva SA conducted the highest number of trials among commercial sponsors.
Premature Labor Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)
Buy the Full Report for More Sponsor Insights into the Premature Labor Marketed and Pipeline Drugs Market
Download a Free Report Sample
Segments Covered in the Report
Premature Labor Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Agonist
- Enzyme Inhibitor
- Receptor Antagonist
- Ion Channel Blocker
Premature Labor Marketed Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Biologic
- Small Molecule
Premature Labor Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Oral
- Injection
- Suppository
- Inhalational
Premature Labor Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Agonist
- Receptor Antagonist
- Enzyme Activator
Premature Labor Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Biologic
- Small Molecule
Premature Labor Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Injection
- Oral
- Suppository
Scope
The key components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the PL market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global PL market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which was the leading MoA for premature labor marketed drugs in 2023?
Most of the drugs followed receptor agonist MoA in 2023 in the premature labor drugs market.
-
Which was the leading molecule type for premature labor marketed drugs in 2023?
In 2023, majority of the marketed drugs for premature labor were small molecules.
-
Which was the leading molecule type for premature labor pipeline drugs in 2023?
In 2023, most of the drugs in development for premature labor were small molecules.
-
Which are the top sponsors in the premature labor marketed and pipeline drugs market?
A few of the top sponsors in the premature labor marketed and pipeline drugs market are Assiut University, Ain Shams University, Chulalongkorn University, ObsEva SA, and GSK plc among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.